Advanced search×

Human endothelial dysfunction: EDRFs.

Pflugers Arch 459(6):1005-13 (2010) PMID 20383717

Since the detection of nitric oxide two and a half decades ago, there has been an incredible boost in endothelial function research, which is fascinating the research community. Physiologically, endothelial cells synthesize a number of vasoactive substances. In particular, several endothelium-derived relaxing factors (EDRFs) have been characterized, whereby nitric oxide is the most important. In humans, endothelial dysfunction is one of the first clinically detectable alterations in the development of atherosclerosis and is characterized by an imbalance in the release of vasoactive substances. Thus, it is the aim of this article to give an overview about endothelial function in humans, to summarize the different possibilities to assess endothelial function in this species, and to give an overview of the role of EDRFs in different cardiovascular diseases.

DOI: 10.1007/s00424-010-0822-4
Version: za2963e q8za4 q8zb0 q8zc7 q8zd3 q8ze0 q8zfb q8zg2

Similar articles you may find interesting…

  1. Endothelial dysfunction in diabetes: multiple targets for treatment.

    Audio, Transactions of the IRE Professio... 459(6):977-94 (2010) PMID 20238124

    We discuss the mechanisms whereby hyperglycaemia, oxidative stress and dyslipidaemia can alter endothelial function and highlight their effects on endothelial nitric oxide synthase (eNOS), the endothelium-dependent hyperpolarising factor (EDHF) pathway(s), as well as on the role of endothelium-deriv...
  2. Prevalence and clinical profile of celiac disease in type 1 diabetes mellitus in north India.

    J Gastroenterol Hepatol 26(2):378-381 (2011) PMID 21261730

      Out of 189 patients of type 1 diabetes mellitus, 21 (11.1%) were diagnosed to have celiac disease on the basis of positive serology (tTGAb) and duodenal histology. The mean age at diagnosis of diabetes was 10.81 ± 7.3 years and that of celiac disease was 13.74 ± 5.71 years, with a d...
  3. Genetics, pathogenesis and clinical interventions in type 1 diabetes.

    Nature 464(7293):1293-300 (2010) PMID 20432533

    We describe current progress, the challenges ahead and the new interventions that are being tested to address the unmet need for preventative or curative therapies....